CompletedNot Applicable

Primary Prevention ICD French Registry

France5,576 participantsStarted 2012-01

Plain-language summary

The indication of implantable cardioverter defibrillator (ICD) therapy for primary prevention of sudden cardiac death has been introduced later in France than in other parts of the World. Overall, we aimed to assess the risk-benefit ratio of this strategy over a 10 year period.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Coronary artery disease or dilated cardiomyopathy with low ejection fraction implanted with an ICD in the setting of primary prevention (criteria at the discretion of the physician) Exclusion Criteria: * Setting of secondary prevention * Other cardiopathies such as congenital, channelopathies, valvulopathies

What they're measuring

Incidences of Appropriate Therapies (ATP and Shocks) and ICD-Related Complications

Timeframe: 3-year

Trial details

NCT IDNCT01992458

SponsorClinique Pasteur

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2013-11

View on ClinicalTrials.gov More Evaluation of Primary Prevention ICD in Real Life trials